JUL 13, 2015 02:32 PM PDT

Colonoscopy Catches Cancer

How important is screening for colon cancer? It’s very important, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE), and reported in Science Daily (https://www.sciencedaily.com/releases/2015/07/150713143655.htm).
German study says that screening colonoscopy increases the chances of colorectal cancer survival.
The study. "Survival in patients with colorectal cancer diagnosed by screening colonoscopy," revealed that patients whose colorectal cancer (CRC) is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test. Conducted in 10 gastroenterology practices in Germany, the study examined 312 patients aged 55 or older, who were diagnosed with CRC between 2003 and 2005. Sixty of them were diagnosed during a screening colonoscopy, having had no symptoms and/or only a negative fecal occult blood test (FOBT). The others had their cancers detected during a diagnostic colonoscopy, after a positive FOBT and/or symptoms including abdominal pain, iron deficiency anemia, weight loss, changes in bowel habits or rectal bleeding.

The patients had not had a previous colonoscopy. They all received endoscopic follow-up care and were followed for as long as 10 years after diagnosis. Patients whose cancer was detected during a screening colonoscopy lived an average of 20.2 months longer than those who had the test after noticing symptoms or having a positive FOBT (diagnostic colonoscopy). Because the latter group was likely to have more advanced stage tumors, people in it had shorter survival times.

Approximately 55 percent of the patients with diagnostic colonoscopy and about 77 percent of the screening colonoscopy patients survived beyond the study time frame. As explained by the lead author, Kilian Friedrich, MD, "We know that screening colonoscopy can prevent cancer by detecting and removing precancerous polyps. Independent of that, this study shows that screening colonoscopy also can contribute to reduced mortality from colorectal cancer by catching tumors at earlier and more treatable stages."

The researchers concluded that, although screening approaches differ between nations, this finding of increased survival among recipients of screening colonoscopy likely applies to other countries. The research corroborated the findings of other organizations.

According to the American Cancer Society, preventing colorectal cancer (and not just finding it early) should be a major reason for getting a screening colonoscopy. Some people can avoid colorectal cancer by having their polyps found and removed. Tests that have the best chance of finding both polyps and cancer are preferred if available. Beginning at age 50, both men and women at average risk for developing colorectal cancer should be tested. Those at an increased or high risk of colorectal cancer -- personal history of colorectal cancer or adenomatous polyps, personal history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) and known family history of a hereditary colorectal cancer syndrome such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colon cancer (HNPCC) -- should begin colorectal cancer screening before age 50 and/or be screened more often (https://www.cancer.org/cancer/colonandrectumcancer/moreinformation/colonandrectumcancerearlydetection/colorectal-cancer-early-detection-acs-recommendations).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 17, 2018
Cell & Molecular Biology
JUL 17, 2018
A New Player in the Control of Cell Division
Oil and water don't mix; cells can take advantage of that phenomenon, phase separation, to organize stuff without using membranes...
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
JUL 30, 2018
Cancer
JUL 30, 2018
Key Markers in Melanoma Disease Progression
Researchers have found key markers in identifying the progression of melanoma by stages....
JUL 31, 2018
Cancer
JUL 31, 2018
Protein Regulation of DNA Replication in Cancer Cells - A New Early Target for Broad Therapeutics?
DNA replication is a carefully regulated process in each cell of the body. Researchers are looking at the mechanism of DNA replication and associated proteins as a therapy target in cancer...
AUG 07, 2018
Cancer
AUG 07, 2018
Is There a Best Time of Day to Administer Chemo?
A common hematologic cancer chemotherapy agent is looked at for its efficacy on solid tumors and specifically evaluates if delivery time during the day affects is anti-tumor activity....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
Loading Comments...